Biogen Inc.

NasdaqGS:BIIB 주식 보고서

시가총액: US$25.3b

Biogen 대차 대조표 상태

재무 상태 기준 확인 6/6

Biogen 의 총 주주 지분은 $16.4B 이고 총 부채는 $6.3B, 이는 부채 대 자기자본 비율을 38.5% 로 가져옵니다. 총자산과 총부채는 각각 $28.3B 및 $12.0B 입니다. Biogen 의 EBIT는 $2.3B 이며 이자보상배율은 11.9 입니다. $1.7B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

38.5%

부채 비율

US$6.29b

부채

이자 보상 비율11.9x
현금US$1.70b
주식US$16.36b
총 부채US$11.95b
총 자산US$28.31b

최근 재무 상태 업데이트

Recent updates

Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter

Oct 31

Does Biogen (NASDAQ:BIIB) Have A Healthy Balance Sheet?

Oct 01
Does Biogen (NASDAQ:BIIB) Have A Healthy Balance Sheet?

What You Can Learn From Biogen Inc.'s (NASDAQ:BIIB) P/E

Sep 04
What You Can Learn From Biogen Inc.'s (NASDAQ:BIIB) P/E

Biogen: Q2 Earnings, Share Price May Have Bottomed Out As CEO Makes Mark

Aug 17

Biogen Stock: Cheapish, But With Few Growth Prospects

Jul 11

Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

May 23
Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)

Apr 29

Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Apr 28
Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

The Price Is Right For Biogen Inc. (NASDAQ:BIIB)

Apr 15
The Price Is Right For Biogen Inc. (NASDAQ:BIIB)

We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings

Feb 21
We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings

Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Feb 16
Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade)

Feb 14

Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly

Jan 31
Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly

Biotech And Pharma Diversification Pays Off

Jan 25

Getting In Cheap On Biogen Inc. (NASDAQ:BIIB) Might Be Difficult

Dec 26
Getting In Cheap On Biogen Inc. (NASDAQ:BIIB) Might Be Difficult

An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued

Oct 21
An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued

Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

Oct 03
Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

Is Biogen Inc. (NASDAQ:BIIB) Trading At A 31% Discount?

Jul 16
Is Biogen Inc. (NASDAQ:BIIB) Trading At A 31% Discount?

Biogen (NASDAQ:BIIB) Has A Pretty Healthy Balance Sheet

Jun 28
Biogen (NASDAQ:BIIB) Has A Pretty Healthy Balance Sheet

재무 상태 분석

단기부채: BIIB 의 단기 자산 ( $6.8B )이 단기 부채( $5.4B ).

장기 부채: BIIB 의 단기 자산( $6.8B )이 장기 부채( $6.5B ).


부채 대 자본 내역 및 분석

부채 수준: BIIB 의 순부채 대 자기자본 비율( 28.1% )은 satisfactory로 간주됩니다.

부채 감소: BIIB 의 부채 대 자기자본 비율은 지난 5년간 42.5% 에서 38.5% 로 감소했습니다.

부채 범위: BIIB 의 부채는 영업 현금 흐름 ( 33.8% )에 의해 잘 충당되었습니다.

이자 보장: BIIB 의 부채에 대한 이자 지급EBIT( 11.9 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기